SCHEMBL25317166

SCHEMBL25317166

O=C1CCc2ccccc2N1C(F)(F)F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.47
TSHR P16473 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
SRD5A1 P18405 4/20 0.40
OPRM1 P35372 1/20 0.40
OPRK1 P41145 1/20 0.40
OPRL1 P41146 1/20 0.40
CYP2A6 P11509 1/20 0.39
CHRM2 P08172 2/20 0.39
CHRM4 P08173 2/20 0.39
CHRM5 P08912 2/20 0.39
CHRM1 P11229 2/20 0.39
CHRM3 P20309 2/20 0.39
DRD2 P14416 1/20 0.39
DRD4 P21917 1/20 0.39
DRD3 P35462 1/20 0.39
HSD17B3 P37058 1/20 0.39
NPC1 O15118 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29601091 0.83 HPGD (0.50) MEN1KMT2AOPRM1OPRK1OPRL1
SCHEMBL3923485 0.83 HPGD (0.50) MEN1KMT2AOPRM1OPRK1OPRL1
SCHEMBL12049027 0.81 MEN1 (0.50) POLBSMN1; SMN2MEN1KMT2ASRD5A1
SCHEMBL5606110 0.73 CA12 (0.40) TSHRSMN1; SMN2MEN1KMT2AHSD17B3
SCHEMBL7086526 0.72 PARL (0.30)
SCHEMBL6333644 0.71 MAOA (0.40) HSD17B3
SCHEMBL1396793 0.71 POLB (0.51) POLBSMN1; SMN2MEN1KMT2ASRD5A1
SCHEMBL3389475 0.71 POLB (0.51) POLBSMN1; SMN2MEN1KMT2ASRD5A1
SCHEMBL11404877 0.71 POLB (0.56) POLBSMN1; SMN2MEN1KMT2ASRD5A1
SCHEMBL2142614 0.71 POLB (0.56) POLBSMN1; SMN2MEN1KMT2ASRD5A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117897370-A Heterocyclic compounds and their use 凯悦施那有限公司 2024-04-16 CN disclosed
WO-2023141432-A2 APOL1 INHIBITORS AND METHODS OF USE MAZE THERAPEUTICS, INC. (US) 2023-07-27 WO disclosed